Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

FIRST: Russia registers COVID vaccine, President Vladimir Putin daughter given a shot

Ruchika Sharma12 Aug 2020 11:46 AM IST

He added that one of his two daughters has received a shot of the vaccine and is feeling well.

Healthcare focused SaaS startup Zealthix raises USD 1.1 million in seed round

Ipca Labs profit leaps over 3-folds to Rs 445.68 crore in Q1

Ruchika Sharma12 Aug 2020 10:30 AM IST

New Delhi: Drug firm Ipca Laboratories on Monday reported over three-fold jump in its consolidated net profit to Rs 445.68 crore for the quarter...

Roche Itovebi recommended by CHMP for EU approval for PIK3CA-mutated, ER-positive, HER2-negative, advanced breast cancer

Roche posts mixed results on phase III studies of etrolizumab in ulcerative colitis

Ruchika Sharma11 Aug 2020 1:53 PM IST

Basel: Roche has announced topline results from its phase III study programme evaluating the investigational medicine etrolizumab in people...

Govt incentives for domestic API to cut supply risk for Indian drug makers: Fitch

Ruchika Sharma11 Aug 2020 12:00 PM IST

The production-linked incentive scheme -- which accounts for Rs 90 crore of planned outlay -- offers an incentive of up to 20 per cent of sales for...

CureVac to raise over Rs 1834 crore IPO in US

Ruchika Sharma11 Aug 2020 10:00 AM IST

Frankfurt: CureVac, one of Germany's leading contenders to develop a COVID-19 vaccine, said it aims to raise up to $245 million in an initial...

Aurobindo Pharma developing COVID-19 vaccine gets shortlisted for BIRAC funding

Ruchika Sharma10 Aug 2020 1:01 PM IST

The company is developing Pneumococcal Conjugate Vaccine (PCV).

Pfizer teams up with Gilead to help manufacture Covid drug remdesivir

Ruchika Sharma10 Aug 2020 12:38 PM IST

US: Pfizer Inc (PFE.N) said on Friday it signed a multiyear agreement to make COVID-19 treatment remdesivir for developer Gilead Sciences Inc...

Unichem Labs to step up API production

Ruchika Sharma10 Aug 2020 12:26 PM IST

"Over-dependence of the Indian pharmaceutical industry on imported APIs exposes it to raw material supply disruptions and pricing volatility," Mody...

Sun Pharma, Lupin recall Clonazepam, Lisinopril tablets respectively in US

Ruchika Sharma10 Aug 2020 11:48 AM IST

New Delhi: Leading drug makers Lupin and Sun Pharma are recalling different products in the US, according to the US Food and Drug Administration...

Chemist Body AIOCD up against MCI Telemedicine Guidelines, writes to PM Modi

Ruchika Sharma10 Aug 2020 11:22 AM IST

The letter pointed out that the MCI Telemedicine guidelines currently are not in accordance to the Drugs and Cosmetics Act

Divi's Labs profit up 80.61 percent to Rs 492.06 crore in Q1

Ruchika Sharma10 Aug 2020 10:00 AM IST

New Delhi: Shares of Divi's Laboratories on Monday rallied over 18 per cent after the company reported 80.61 per cent rise in consolidated net...

Sub District Hospital converted to full-fledged COVID facility in Ponda: Goa CM Pramod Sawant

Ruchika Sharma10 Aug 2020 9:15 AM IST

Panaji: The sub-district hospital in Ponda in North Goa will be converted into a COVID-19 facility to ensure that best of healthcare facilities...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok